SAB Biotherapeutics (SABS) Shares Issued (2020 - 2026)

SAB Biotherapeutics has reported Shares Issued for 6 years, with the latest figure at $113116.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $113116.0; the trailing twelve-month figure through Mar 2026 stood at $113113.0 (changed N/A YoY), and the FY2024 full-year result was $20409.0, down 99.97% from the prior year.
• Shares Issued for Q1 2026 stood at $113116.0, up from -$3.0 in the prior quarter.
• The five-year high for Shares Issued was $59.6 million in Q4 2023, with the low at -$3.0 in Q4 2024.
• Historically, Shares Issued has averaged $6.0 million across 4 years, with a median of $5130.0 in 2022.
• Annual changes were most pronounced in 2023 — Shares Issued surged 5964968100.0% — and 2024, when it plunged 100.0%.
• SAB Biotherapeutics' Shares Issued stood at -$1.0 in 2022, then surged by 5964968100.0% to $59.6 million in 2023, then sank by 100.0% to -$3.0 in 2024, then jumped by 3770633.33% to $113116.0 in 2026.
• The last three Shares Issued figures came in at $113116.0 (Q1 2026), -$3.0 (Q4 2024), and $20412.0 (Q1 2024), per Business Quant data.